EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Slideshows|October 30, 2018
Lichenoid Eruptions: Can You Match that Rash with the Dx?
Author(s)Jonathan A. Schneider, DO
Test your visual diagnostic skills with an up-close look at 3 papulosquamous rashes and see if you can make a Dx match.
Advertisement
The topic is lichenoid dermatoses. The overview in the slides below lets you test your visual diagnostic skills by looking at 3 different rashes, all asymptomatic, all present for from several weeks to several months, and all in patients with medical histories that were non-contributory.Can you match that rash x3? Â
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
2
5 FDA Decisions for Primary Care to Know from September 2026
3
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
4
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
5